COVID – 19 | Vaccination Update – Day 511

ad
Single-shot COVID-19 vaccine protects non-human primates
Single-shot COVID-19 vaccine protects non-human primates

India’s COVID-19 vaccination coverage has crossed 194.90 Crore (1,94,90,76,635today. More than 13 lakh (13,15,143) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10407562
2nd Dose 10047108
Precaution Dose 5379014
FLWs 1st Dose 18420412
2nd Dose 17595894
Precaution Dose 9137025
Age Group 12-14 years 1st Dose 35020889
  2nd Dose 19114567
Age Group 15-18 years 1st Dose 59810625
  2nd Dose 46831242
Age Group 18-44 years 1st Dose 557533014
2nd Dose 494051507
Precaution Dose 1397249
Age Group 45-59 years 1st Dose 203313888
2nd Dose 191735975
Precaution Dose 1750288
Over 60 years 1st Dose 127143444
2nd Dose 119643786
Precaution Dose 20743146
Cumulative 1st dose administered 1011649834
Cumulative 2nd dose administered 899020079
Precaution Dose 38406722
Total 1949076635

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 10th June, 2022 (511th Day)
HCWs 1st Dose 46
2nd Dose 609
Precaution Dose 13686
FLWs 1st Dose 111
2nd Dose 1260
Precaution Dose 38443
Age Group 12-14 years 1st Dose 95278
  2nd Dose 224235
Age Group 15-18 years 1st Dose 35390
  2nd Dose 94132
Age Group 18-44 years 1st Dose 32172
2nd Dose 375495
Precaution Dose 54448
Age Group 45-59 years 1st Dose 4395
2nd Dose 82130
Precaution Dose 36661
Over 60 years 1st Dose 4433
2nd Dose 57657
Precaution Dose 164562
Cumulative 1st dose administered 171825
Cumulative 2nd dose administered 835518
Precaution Dose 307800
Total 1315143

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply